Quarterly report pursuant to Section 13 or 15(d)

Investment in Joint Venture (Investee Losses in Excess of Investment)

v3.19.2
Investment in Joint Venture (Investee Losses in Excess of Investment)
6 Months Ended
Jun. 30, 2019
Investment in Joint Venture (Investee Losses in Excess of Investment)  
Note 3. Investment in Joint Venture (Investee Losses in Excess of Investment)

Pursuant to the Enfission operating agreement, both partners agreed that Enfission will serve as an exclusive vehicle to develop, license, and sell nuclear fuel assemblies based on Company-designed metallic fuel technology and other advanced nuclear fuel intellectual property licensed to Enfission by the Company and Framatome or their affiliates. The joint venture builds on the joint fuel development and regulatory licensing work under previously signed agreements initiated in March 2016.

 

The Enfission operating agreement provided that the Company and Framatome each hold 50% of the total issued Class A voting membership units of the joint venture.

 

The Company's equity in losses in excess of its investment are accounted for under the equity method consisted of the following as of June 30, 2019 (rounded in millions):

 

Investment Name

 

Ownership

Interest

 

Carrying

Amount

 

 

Enfission, LLC

 

50

%

 

Total contributions

 

$

9.1

 

Less: Share of the loss in investment in Enfission

 

(9.0

)

Total - Equity Method Investment

 

$

0.1

 

The Company invested approximately $9.1 million in Enfission and Framatome invested approximately $2.9 million of equity for the period from January 24, 2018 (Date of Inception of Enfission) to June 30, 2019. The cash balance in Enfission at June 30, 2019 was approximately $1.5 million. During the six months ended June 30, 2019, Enfission incurred a loss of approximately $4.5 million, and accordingly, the Company recorded its share of the loss in investment in Enfission, in accordance with the provisions in the joint venture operating agreement, of approximately $3.3 million in the accompanying condensed consolidated statement of operations for the six months ended June 30, 2019.

 

The Company was committed to fund Enfission for its share of Enfission’s liabilities at June 30, 2019. The Company currently expects to continue providing additional equity contributions in 2019 and for the foreseeable future.

 

Summarized balance sheet information for the Company’s equity method investee Enfission as of June 30, 2019 and December 31, 2018 is presented in the following table (rounded in millions):

 

 

June 30,

2019

 

December 31,

2018

 

Assets

 

Cash

 

$

1.5

 

$

0.7

 

Other current assets

 

0.8

 

0.7

 

Total assets

 

$

2.3

 

$

1.4

 

Liabilities and equity

 

Total liabilities

 

$

2.5

 

$

1.9

 

Equity

 

(0.2)

 

(0.5)

 

Total liabilities and equity

 

$

2.3

 

$

1.4

 

Summarized income statement information for the Company’s equity method investee Enfission is presented in the following table for the six months ended June 30, 2019 and for the period from January 24, 2018 (Date of Inception) to June 30, 2018 (rounded in millions):

 

 

For the Six Months Ended June 30,

2019

 

For the period from January 24, 2018 (Date of Inception) to June 30, 2018

 

Net sales and revenue

 

$

0.0

 

$

0.0

 

Research and development costs

 

3.8

 

2.3

 

Administrative expenses

 

0.7

 

0.5

 

Total Operating Loss

 

$

4.5

 

$

2.8

 

Loss from operations

 

$

4.5

 

$

2.8

 

Net loss

 

$

4.5

 

$

2.8

 

As of June 30, 2019, and December 31, 2018, the total receivable due from Enfission was approximately $0.5 million and $0.1 million, respectively, which represents consulting fees Lightbridge charged to Enfission and reimbursable expenses paid by Lightbridge on Enfission’s behalf (see Note 8. Related Party Transactions). Based on an evaluation of this equity method investment, we determined that no OTTI has occurred as of June 30, 2019.